Robert N. Eisenman, PhD


Robert N. Eisenman, PhD

Basic Sciences Division, Fred Hutch

Translational Data Science Integrated Research Center (TDS IRC), Fred Hutch

Fax: 206.667.6522
Mail Stop: A2-025

Dr. Robert "Bob" Eisenman’s research is focused on the MYC network: a group of genes that are important for normal growth and development but, when mutated, are profoundly involved in a multitude of human cancers. All of these factors encode gene-regulatory proteins that control cellular programs in response to signals from the environment. Dr. Eisenman’s laboratory uses genetic and molecular analyses to understand in detail the functions of these proteins and the pathways they control with the eventual goal of modulating their functions as a means of treating cancers.


Postdoctoral, Massachusetts Institute of Technology, Cell Biology, 1976

Postdoctoral, Institut Suisse de Recherche Experimentale sur le Cancer, Virology, 1975

PhD, University of Chicago, Biophysics, 1971

Find a Clinical Trial

Dr. Eisenman in the News

The Myc network’s multiple functions in spermatogenesis

Science Spotlight - December 20, 2021

MGA & MYC: mega-sized players in cancer progression

Science Spotlight - August 16, 2021

In cancer, the context 'makes' the mutation

Hutch News - June 01, 2020

MYC can’t cause havoc in B cells without MAX

Science Spotlight - October 21, 2019

For the Media

The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.

Email or call 206.667.2210